Nigeria documents

Annual progress reports

Countries no longer submit annual progress reports. Please refer to the joint appraisal report and Multi-Stakeholder Dialogue documents on this page.

Annual progress report Nigeria 2007

Annual progress report Nigeria 2014

Annual progress report Nigeria 2006

Annual progress report Nigeria 2013

Annual progress report Nigeria 2004

Annual progress report Nigeria 2012

Annual progress report Nigeria 2005

Annual progress report Nigeria 2011

Annual progress report Nigeria 2003

Annual progress report Nigeria 2010

Annual progress report Nigeria 2002

Annual progress report Nigeria 2009

Annual progress report Nigeria 2001

Annual progress report Nigeria 2008

The joint appraisal report and Multi-Stakeholder Dialogue

The joint appraisal is an in-country, multi-stakeholder review of the implementation progress and performance of Gavi's vaccine and cash grant support to the country, and of its contribution to improved immunisation outcomes. The outcome of the appraisal is the completed "joint appraisal report" that captures Gavi grant performance as well as implementation challenges. The joint appraisal report informs discussions with national coordination mechanisms on areas where greater national investments and efforts, as well as technical support, are needed.

In 2020/2021, as a result of the COVID-19 pandemic, Multi-stakeholder dialogue (MSD) documents temporarily replaced the traditional Joint Appraisal to ensure that Gavi’s continuing support to the EPI programme be aligned with realities at country level.

Multi-stakeholder dialogue Nigeria 2020

Joint Appraisal Nigeria 2019

Joint Appraisal Nigeria 2017

Joint Appraisal Nigeria 2016

Joint Appraisal Nigeria 2015

Joint Appraisal Nigeria 2014

Approved proposals

All eligible countries are invited to submit proposals for Gavi support. 

Proposal for NVS MFU support 2023:Nigeria

Date of Gavi approval:

Proposal for NVS HPV support 2023:Nigeria

Date of Gavi approval:

Proposal for Rota addit doses support 2021:Nigeria

Date of Gavi approval:

Proposal for NVS-YF diagnostics support 2020 : Nigeria

Date of Gavi approval:

Proposal for HSS (2019-2023): Nigeria

Date of Gavi approval:

Proposal for CCEOP support (2019-2023): Nigeria

Date of Gavi approval:

Proposal for NVS - Measles 2nd dose, Measles SIA, YF Campaign (2019-2020): Nigeria

Date of Gavi approval:

Proposal for NVS - Measles Follow-up camp 2019 : Nigeria

Date of Gavi approval:

Proposal for NVS - measles follow-up campaign (2017-2020) :Nigeria

Date of Gavi approval:

Proposal for MenA Routine Support 2016: Nigeria

Date of Gavi approval:

Proposal for HSS Support (2019-2023): NIgeria

Date of Gavi approval:

Proposal for NVS - Measles SIA support: Nigeria(2)

Date of Gavi approval:

Proposal for NVS - IPV support: Nigeria

Date of Gavi approval:

Proposal for MenA support: Nigeria

Date of Gavi approval:

Proposal for NVS - Measles SIA support: Nigeria

Date of Gavi approval:

Proposal for NVS - PCV - 2nd phase support: Nigeria

Date of Gavi approval:

Proposal for NVS - YF campaign support: Nigeria

Date of Gavi approval:

Proposal for NVS - PCV support: Nigeria

Date of Gavi approval:

Proposal for NVS - Penta support: Nigeria

Date of Gavi approval:

Proposal for NVS- MenA campaign (2011 - 2013): Nigeria

Date of Gavi approval:

Proposal for ISS support: Nigeria

Date of Gavi approval:

Proposal for HSS support: Nigeria

Date of Gavi approval:

Proposal for ISS support: Nigeria (2001)

Date of Gavi approval:

Comprehensive multi-year plans, Financial sustainability plans, National Immunisation Strategy

The comprehensive multi-year plan (cMYP) is a single plan which consolidates several immunisation activities. It is a key planning and management tool for national immunisation programmes. It addresses global, national, and subnational immunisation objectives and strategies, and evaluates the costs and financing of the programme in line with the WHO-UNICEF Global Immunization Vision and Strategy 2006-2015. Gavi requires countries to submit a cMYP along with the standard proposal form when applying for Gavi support (ISS, INS, and NVS). In 2006, over 50 countries had developed cMYPs using the WHO-UNICEF cMYP guidelines and costing tool.
The cMYP replaces the financial sustainability plan (FSP), used to assess the funding challenges of a country's national immunisation programme within the broader health financing context and to describe the government’s approach to mobilising and effectively using resources to support medium- and long-term immunisation objectives. 

Comprehensive Multi-Year Plan Nigeria 2018-2028

Comprehensive multi-year plan for 2006-2010

cMYPs Nigeria 2006-2010

Country co-financing information sheet

The country-specific co-financing sheets provide up-to-date information on countries’ eligibility status, co-financing fulfilment and requirements. They also give a summary of government health expenditure, including immunisation financing.

Specifically, the sheets provide a history of the Gavi-supported vaccines introduced per country, the country’s co-financing payments to date and its co-financing requirements for the current year. In case the country has defaulted on its co-financing requirements, there is an overview of the co-financing arrears of the previous year. Finally, the sheets provide co-financing projections for the next five years based on our latest forecasts.

The information sheets are updated at least twice per year to account for new information on countries’ co-financing fulfilment (in the first quarter) and eligibility status (in the third quarter).

Co-financing information sheet Nigeria

Data quality audit

The DQA has been developed by WHO to help evaluate the quality of countries' health information systems and to verify the accuracy of reported data. Read more. 

DQAs/SFPs Nigeria

Decision Letters and Partnerships Agreement

The Decision Letter or Partnership Framework Agreement provides a summary of the details of the new approval or continuation of a Gavi window of support, following the independent review of a new application or annual progress report submitted by a country.

Decision Letter COVID19 Nigeria 2023

Decision-Letter HPV Nigeria 2023

Decision Letter PCV Nigeria 2022

Decision Letter PENTA Nigeria 2022

Decision Letter RV Nigeria 2022

Decision Letter COVID19 Nigeria 2022

Decision Letter PENTA Nigeria 2021

Decision Letter PCV R Nigeria 2021

Decision Letter M R 1&2 Nigeria 2021

Decision Letter MENA R Nigeria 2021

Decision Letter IPV R Nigeria 2021

Decision Letter PCV R Nigeria 2020

Decision Letter M R 1&2 Nigeria 2020

Decision Letter IPV Nigeria 2020

Decision Letter PENTA R Nigeria 2020

Decision Letter MENA R Nigeria 2020

Decision Letter YF Nigeria 2020

Decision Letter MENA Nigeria 2019

Decision Letter IPV Nigeria 2019

Decision Letter PENTA R Nigeria 2019

Decision Letter PCV Nigeria 2019

Decision Lettre NVS Nigeria 2017 (2)

Decision Letter NVS Nigeria 2014(4)

Decision letter NVS Nigeria 2012

Decision Letter Nigeria ISD 2019

Decision Lettre NVS Nigeria 2017 (3)

Decision Letter NVS Nigeria 2014(2)

Decision Letter Nigeria Measles 2019

Decision Lettre NVS Nigeria 2017 (4)

Decision Letter NVS Nigeria 2014

Decision Letter Nigeria YF 2019

Decision Letter Devices Nigeria 2017

Decision Letter NVS Nigeria 2014(3)

Decision Letter Nigeria Injection Safety Devices 2018

Decision Letter NVS Nigeria 2017

Partnership Framework Agreement Nigeria

Decision Letter Nigeria PCV Switch 2018

Decision Letter NVS and Devices Nigeria 2016

Decision letter NVS Nigeria 2013(3)

Decision Letter YF Campaign 2018

Decision Letter NVS Nigeria 2016

Decision letter NVS Nigeria 2013(2)

Decision Lettre Devices Nigeria 2017 (2)

Decision Letter NVS Nigeria 2015

Decision letter NVS Nigeria 2013

HSS evaluation

The HSS evaluation team visited several countries (in depth country studies) and conducted a number of country desk reviews (Country desk studies).

HSS evaluation Nigeria

COVAX Technical Assistance Plans

In September 2020, the Gavi Board approved resources from core funding to focus on urgent technical assistance (TA) needs for 92 AMC economies, for the planning and preparation for the introduction of the COVID-19 vaccine. The plan includes sets of activities, milestones and budget for a given year.

COVAX Technical Assistance Plan Nigeria 2021

Targeted country assistance plans

Targeted country assistance (TCA) are resources provided to in-country partners under Gavi’s partners’ engagement framework (PEF). A country’s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.

Targeted Country Assistance Plan Nigeria 2022

Targeted Country Assistance Plan Nigeria 2019

Targeted Country Assistance Plan Nigeria 2020

Targeted Country Assistance Plan Nigeria 2021

Targeted country assistance plan Nigeria 2017

Subscribe to our newsletter